NCT06798363View on ClinicalTrials.gov

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

August 1, 2026

Conditions

Infantile Hemangioma

Interventions

DRUG

propranolol

different dose

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

West China Hospital

OTHER